Baku 23° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Azerbaijani Version 
Russian Version Latest News
21:32
UN: Quake in Afghanistan could affect ‘hundreds of thousands'
Other countries21:15
Dushanbe, Beijing discuss co-op in Central Asia–China format
Other countries21:01
Moody's: Azerbaijan becomes regional leader in renewable energy dev't
Energy20:56
OSCE PA President welcomes decision to close Minsk process
Foreign policy20:49
Claims about hunger strike by Armenian-origin terrorist in Azerbaijani custody are false
Domestic policy20:38
EU donates €1M in humanitarian emergency funding to Afghanistan
Other countries20:25
Moody's: IFIs can help bridge climate finance gaps in Azerbaijan
Finance20:15
Photo
Azerbaijan, Türkiye sign Action Plan on Labor & Social Security for 2026-2027
Foreign policy20:09
Photo